Pasithea Therapeutics Corp. - 10-Q Filing
Pasithea Therapeutics Corp. reports Q3 2026 financial results featuring significant warrant activity and research/development expense disclosures.
Tickers: $KTTA
More Regulatory news
- BCP Investment Corp - 8-K Filing
- Mistras Group, Inc. - 8-K Filing
- CareTrust REIT, Inc. - 8-K Filing
- RTB Digital, Inc. - 10-Q Filing
- CISO Global, Inc. - 10-Q Filing
- MANGOCEUTICALS, INC. - 8-K Filing
- GBank Financial Holdings Inc. - 10-Q Filing
- Canary Staked SUI ETF - 10-Q Filing
- Canary Marinade Solana ETF - 10-Q Filing
- Cingulate Inc. - 10-Q Filing